TrialBMC cancer2020

Accuracy of detecting residual disease after neoadjuvant chemoradiotherapy for esophageal squamous cell carcinoma (preSINO trial): a prospective multicenter diagnostic cohort study.

Xiaobin Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.